20.510 articles found

Sort:

Source record

On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.

Casati C, Agnoli A, Jori A, Dolfini E.

Z Neurol · 1973-04-01

DOI: 10.1007/bf00315939PMID: 4121468

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Interaction between levodopa and methyldopa.

Gibberd FB, Small E.

Br Med J · 1973-04-01

DOI: 10.1136/bmj.2.5858.90PMID: 4573316

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Combined therapy of parkinsonism using amantadine].

Umbach W, Oppel F.

Munch Med Wochenschr · 1973-04-01

PMID: 4740225

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

MK 486 and levodopa in treatment of Parkinsonism.

Lieberman AN, Derby BM, Feigenson J, Goodgold A, Nesbitte J, Resurreccion EC, Valdivia F.

Dis Nerv Syst · 1973-04-01

PMID: 4711885

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].

Christiani K, Möller WD.

Munch Med Wochenschr · 1973-04-01

PMID: 4197759

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Lithium and levodopa in parkinsonism.

Dalén P, Steg G.

Lancet · 1973-04-01

DOI: 10.1016/s0140-6736(73)91390-1PMID: 4123864

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Therapy of parkinsonism].

Paal G.

Med Welt · 1973-04-01

PMID: 4744982

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].

Völler GW, Muschard F.

Med Welt · 1973-04-01

PMID: 4750934

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Psychiatric complications of L-Dopa treatment of parkinsonism].

Refsum H.

Tidsskr Nor Laegeforen · 1973-04-01

PMID: 4755082

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.

Muenter MD, Dinapoli RP, Sharpless NS, Tyce GM.

Mayo Clin Proc · 1973-03-01

PMID: 4570387

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Longtime study on the effects of L-dopa therapy in parkinsonism].

Fischer PA, Schneider E, Jacobi P, Maxion H.

Nervenarzt · 1973-03-01

PMID: 4572536

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Sebaceous gland secretion in Parkinson's disease during L-dopa treatment.

Kohn SR, Pochi PE, Strauss JS, Sax DS, Feldman RG, Timberlake WH.

J Invest Dermatol · 1973-03-01

DOI: 10.1111/1523-1747.ep12682040PMID: 4699650

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.